"Gangliosides" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A subclass of ACIDIC GLYCOSPHINGOLIPIDS. They contain one or more sialic acid (N-ACETYLNEURAMINIC ACID) residues. Using the Svennerholm system of abbrevations, gangliosides are designated G for ganglioside, plus subscript M, D, or T for mono-, di-, or trisialo, respectively, the subscript letter being followed by a subscript arabic numeral to indicated sequence of migration in thin-layer chromatograms. (From Oxford Dictionary of Biochemistry and Molecular Biology, 1997)
| Descriptor ID |
D005732
|
| MeSH Number(s) |
D09.400.410.420.025.475 D10.390.470.025.475 D10.570.877.360.025.475
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Gangliosides".
Below are MeSH descriptors whose meaning is more specific than "Gangliosides".
This graph shows the total number of publications written about "Gangliosides" by people in this website by year, and whether "Gangliosides" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2008 | 1 | 0 | 1 |
| 2010 | 1 | 0 | 1 |
| 2016 | 1 | 0 | 1 |
| 2022 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Gangliosides" by people in Profiles.
-
In Silico Conformational Features of Botulinum Toxins A1 and E1 According to Intraluminal Acidification. Toxins (Basel). 2022 09 17; 14(9).
-
Comparative pharmacokinetics, safety, and tolerability of two sources of ch14.18 in pediatric patients with high-risk neuroblastoma following myeloablative therapy. Cancer Chemother Pharmacol. 2016 Feb; 77(2):405-12.
-
Abnormal gangliosides are localized in lipid rafts in Sanfilippo (MPS3a) mouse brain. Neurochem Res. 2012 Jun; 37(6):1372-80.
-
Anti-GD2 antibody with GM-CSF, interleukin-2, and isotretinoin for neuroblastoma. N Engl J Med. 2010 Sep 30; 363(14):1324-34.
-
Absence of oligodendroglial glucosylceramide synthesis does not result in CNS myelin abnormalities or alter the dysmyelinating phenotype of CGT-deficient mice. Glia. 2010 Mar; 58(4):391-8.
-
Anti-ganglioside antibody induction by swine (A/NJ/1976/H1N1) and other influenza vaccines: insights into vaccine-associated Guillain-Barré syndrome. J Infect Dis. 2008 Jul 15; 198(2):226-33.
-
Drastically abnormal gluco- and galactosylceramide composition does not affect ganglioside metabolism in the brain of mice deficient in galactosylceramide synthase. Neurochem Res. 1999 Apr; 24(4):471-4.
-
Synthesis and translocation of gangliosides and glycoproteins during urethane anesthesia. J Neurochem. 1988 May; 50(5):1369-74.
-
Specificity of ganglioside binding to rat macrophages. Mol Immunol. 1986 Nov; 23(11):1267-73.
-
AB variant GM2 gangliosidosis: cerebrospinal fluid and neuropathologic characteristics. Neurology. 1986 Mar; 36(3):438-40.